Relay Therapeutics Earnings Estimate

By analyzing Relay Therapeutics' earnings estimates, investors can diagnose different trends across Relay Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Relay Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options. Relay Therapeutics is projected to generate -0.6385 in earnings per share on the 31st of December 2025. Relay Therapeutics earnings estimates module stress-tests analyst consensus about projected Relay Therapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Relay Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Relay Therapeutics' earnings estimates, investors can diagnose different trends across Relay Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about (285.8 M) in 2024. Pretax Profit Margin is likely to drop to -14.06 in 2024Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relay Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.